Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.82 |
| ▸ | MAPT | P10636 | 5/20 | 0.82 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.74 |
| ▸ | THRB | P10828 | 2/20 | 0.74 |
| ▸ | GFER | P55789 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | GAA | P10253 | 4/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | TP53 | P04637 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 6/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenyl Phenylcarbamate SCHEMBL272994 | 0.96 | ALDH1A1 (0.76) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL9480551 | 0.92 | ALDH1A1 (0.72) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL21295428 | 0.92 | SMN1; SMN2 (0.74) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL30407133 | 0.92 | ALDH1A1 (0.72) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL9125722 | 0.92 | ALDH1A1 (0.75) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL25203498 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| Phenyl 4-Chlorophenylcarbamate SCHEMBL6258165 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL1171803 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL95682 | 0.91 | ALDH1A1 (0.70) | ALDH1A1MAPTRAD51KMT2AMEN1 | |
| SCHEMBL6816927 | 0.91 | MAPT (0.73) | ALDH1A1MAPTRAD51KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10450265-B2 | Method for producing amides or polyamides by using aromatic carbamates by way of isocyanates as precursors through catalyzed thermal processes and method for producing aromatic carbamate precursors from aromatic amines | GREAT EASTERN RESINS INDUSTRIAL CO., LTD. (TW) | 2019-10-22 | — | — | US | disclosed |
| US-6143917-A | FROM A DIARYL CARBONATE AND AN AMINE COMPOUND HAVING AT LEAST ONE HYDROGEN ATOM LOCATED AT AN N-POSITION UNDER MODERATE CONDITIONS AT A HIGH REACTION RATE WITH A HIGH SELECTIVITY AND WITH A HIGH YIELD | UBE INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| EP-0902014-A1 | PROCESS FOR PRODUCING ARYL CARBAMATES | UBE INDUSTRIES LIMITED (JP) | 1999-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450265-B2 | Method for producing amides or polyamides by using aromatic carbamates by way of isocyanates as precursors through catalyzed thermal processes and method for producing aromatic carbamate precursors from aromatic amines | NAAA, NISCH, CPS1 | ALDH1A1 2398/4885MAPT 916/4885RAD51 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.